AIM ImmunoTech Inc. — Director's Dealing 2019

Oct 17, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AIM ImmunoTech Inc. (AIM)
CIK: 0000946644
Period of Report: 2019-10-15

Reporting Person: APPELROUTH STEWART (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-17	Common Stock	J	6911	$0.55	Acquired	47598	Direct

Footnotes

F1: Shares issued for 50 percent of Director's Fee for the first half of October, 2019.